Many drugs are weak bases and can be accumulated into liposomes in response to a pH gradient to achieve high internal drug concentrations. This study is aimed at gaining an understanding of the relationship between the retention of the fluoroquinolone antibiotic ciprofloxacin in liposomes and the intraliposomal form and location of this drug.
Introduction
Liposomes are widely used as carriers for anticancer, antibiotic and antifungal drugs [1, 2] . Encapsulation of drugs in liposomes can reduce their acute toxicity and may result in increased e¤cacy due to the ability of small, long-circulating liposomes to preferentially accumulate at the site of disease. Increased potency of antibiotics can occur as a consequence of the natural clearance of liposomes from the circulation by phagocytic cells, which are fre-quently the site where intracellular pathogens localize [3] . Cipro£oxacin, a synthetic quinolone derivative with activity against a broad spectrum of Gram-positive and Gram-negative bacteria, is one of the most widely used antibiotics for the treatment of respiratory, urinary and enteric infections [4, 5] . Its bacterial action results from the inhibition of the enzyme DNA gyrase which is needed for the synthesis of bacterial DNA [6, 7] . However, the use of liposomal carriers for cipro£oxacin is severely impaired by rapid leakage of this drug from liposomes.
Cipro£oxacin is one of a large number of drugs with weak base character which can be actively accumulated in liposomes in response to a pH gradient [8^10] . However, while some drugs such as the anticancer drug, doxorubicin, are only slowly released from the liposomal carrier in vitro or in vivo, other drugs including cipro£oxacin leak out rapidly. In order to improve these systems knowledge about the relationship between retention and the form and location of these drugs in liposomes is important. Encapsulated drugs could be partitioned in the membrane, reside in the aqueous interior as a precipitate or remain in solution. The nature and location of the drug in the liposome interior together with factors such as membrane permeability determine how quickly the encapsulated drug can respond to disturbances of thermodynamic equilibria such as depletion of the pH gradient.
Cipro£oxacin loaded into liposomes in response to transmembrane pH gradients has been suggested to be precipitated out in the liposome interior [11] . Reasons proposed for its rapid release in vitro and in vivo were larger solubility product than other drugs which are precipitated, other kind of drug association within the vesicles, pK values close to neutrality which results in higher fractions of the neutral membrane-permeable form or rupture of the liposomal membrane by growing crystals.
This study was aimed at achieving a better understanding of the factors which determine the retention of cipro£oxacin after accumulation into large unilamellar vesicles driven by a transmembrane proton gradient (vpH), where the vpH was generated in response to entrapped ammonium sulfate. Because of the sensitivity of NMR signals to changes in molecular environment and dynamics, the interaction of cipro£oxacin with itself and with phospholipid vesicles was investigated using 1 H-NMR spectroscopy. It is shown that cipro£oxacin is located in the aqueous interior of the liposomes in the form of stacks consisting of a small number of cipro£ox-acin molecules. The drug is not precipitated although the intraliposomal cipro£oxacin concentration can exceed its solubility by orders of magnitude. This is the ¢rst time such a phenomenon has been observed in a liposomal system. Previous work has shown that other drugs such as doxorubicin can be entrapped at concentrations substantially higher than their aqueous solubility; however, this can be explained by precipitation or partitioning into the liposome membrane [9, 12] . The high solubility of entrapped cipro£oxacin together with the rapid exchange into and out of the lipid membrane allow it to respond very quickly to changes in thermodynamic equilibria such as depletion of the pH gradient.
Materials and methods

Materials
Dipalmitoylphosphatidylcholine (DPPC) and palmitoyl-oleoyl PC (POPC) were purchased from Avanti Polar Lipids (Alabaster, AL), and were s 99% pure. Cholesterol (chol) and ammonium sulfate (AS) were obtained from Sigma (St. Louis, MO), and deuterium oxide (D 2 O) and sodium 2,2-dimethyl-2-silapentane-5-sulfonate (DSS) from Cambridge Isotope Laboratories (Andover, MA 
Preparation of liposomes
DPPC/chol (55:45 mol/mol) liposomes were prepared by dissolving the lipids in t-butanol and lyophilizing for 6 h. POPC was directly used for the preparation of POPC liposomes. Multilamellar vesicles (MLVs) were formed by hydrating the lipid with a 300 mM ammonium sulfate solution followed by ¢ve freeze^thaw cycles [13] . The lipid concentration was approximately 100 mM. The resulting MLVs were directly extruded 10 times through two stacked Nuclepore polycarbonate ¢lters with pore sizes of 80, 100 and 200 nm to obtain LUVs of corresponding sizes. The size of the vesicles was measured by dynamic light scattering (Nicomp Particle Sizing Systems, Santa Barbara, CA). Average hydrodynamic diameters were found to be 115 þ 20 nm and 190 þ 30 nm for the DPPC/chol LUVs extruded through 100 and 200 nm ¢lters, respectively, and 75 þ 20 nm and 155 þ 30 nm for POPC LUVs extruded through 80 and 200 nm ¢lters. Lipid concentrations were determined using the phosphorus assay of Fiske and Subbarow [14] .
Generation of the pH gradient
The ammonium sulfate gradient was generated by exchanging the extravesicular solution with 150 mM sodium chloride (NaCl) on G-50 Sephadex spin columns [15] . This concentration gradient drives the formation of a pH gradient of approximately 3 units. For the NMR experiments the spin columns had to be repeatedly washed with a 150 mM NaCl/D 2 O solution in order to remove residual ethanol in the Sephadex gel. The pH gradient was determined using [ 14 C]methylamine and was performed as previously described [16] .
Uptake of cipro£oxacin into LUVs
Cipro£oxacin was added to these liposomes and the samples were incubated for 15 min at 60³C. Encapsulation e¤ciencies were determined as follows. Residual unentrapped drug was removed by size exclusion chromatography on Sephadex G50 spin columns and cipro£oxacin concentrations determined by scintillation counting using [ 14 C]cipro£oxacin or UV-absorption at 274 nm after a Bligh^Dyer extraction into 200 mM NaOH as aqueous phase [17] . Lipid concentrations were determined either by scintillation counting using the radiolabeled lipid [ 3 H]CHE or by the Fiske^Subbarow phosphorus assay. Typical encapsulation e¤ciencies for molar drug-to-lipid (d/l; mol/mol) ratios up to 0.6 were between 90% and 95%. The average size of the liposomes was not a¡ected by the uptake of the drug as was shown by dynamic light scattering measurements.
Drug release experiments
In vitro release experiments were carried out in test tubes by diluting samples 1:1 with normal mouse serum and incubation at 37³C. The pH gradient was depleted by incubation in 150 mM ammonium acetate solution at 25³C. Samples at various time points were taken and concentrations of entrapped drugs were determined following removal of unentrapped drug by size exclusion chromatography as described above for drug uptake experiments.
Trapped volume determination
Trapped volumes of the liposomes were determined under the same conditions as for the drug uptake using radiolabeled sucrose or glucose as aqueous trap markers. 100 Wmol DPPC/chol (55:45 mol%) were hydrated in 1 ml of a 300 mM ammonium sulfate, 10 mM sucrose or glucose solution spiked with 0.5 WCi 
Solubility
Solubilities were determined at 25³C as a function of ammonium sulfate concentration and pH and in the presence of liposomes. For the concentration dependence, excess drug was added to 5 mM sodium acetate solutions containing the appropriate amounts of ammonium sulfate. If necessary the pH was adjusted to pH 5. DPPC/chol liposomes in 25 mM ace-tate bu¡er at pH 5 were added to 10 mM cipro£ox-acin in water. Lipid concentrations ranged from 5 to 20 mM. Subsequently ammonium sulfate was added to a concentration of 300 mM. It was not necessary to readjust the pH. The pH dependence was determined in 300 mM ammonium sulfate solutions which were titrated with NaOH to the appropriate pHs. The solutions contained 3 mM CHES, Hepes and citric acid to allow better pH adjustment. No attempt was made to keep the ionic strength constant since its increase by NaOH addition has no signi¢cant e¡ect on the solubility at 300 mM ammonium sulfate. Subsequently the samples were equilibrated for 24 h at 25³C and the concentration of cipro£oxacin determined after centrifugation for 15 min at 3000Ug in the supernatant by UV absorption at 274 nm, as described previously.
Binding studies
Binding studies were performed using a Beckmann TL-100 ultracentrifuge with a TLA 100.2 ¢xed-angle rotor. DPPC/chol 200 nm LUVs (2.5 mM lipid) were incubated in the presence of increasing concentrations of cipro£oxacin (0.25^10 mM) at 25³C for 2 h in 20 mM sodium acetate/100 mM NaCl (pH 5) and pelleted by ultracentrifugation for 90 min at a RCF max of 436 000Ug (100 000 rpm). The supernatants as well as the lipid pellets were assayed for drug and lipid using the methods described above. The pellets were quickly rinsed with cold bu¡er and resuspended in H 2 O. The amount of drug associated with the lipid pellets makes up a few percent (93%) of the total drug. This, however, does not take the aqueous volume which is included in the pellets into account. Therefore, the actual amount of partitioned drug is even lower. The lipid in the supernatant was less than 5%. The level of association cannot be determined by assaying the drug in the supernatant using £uorescence or UV spectroscopy, as it corresponds to the accuracy of the measurements.
1 H-NMR experiments
All salts used in the 1 H-NMR experiments were dissolved in D 2 O and subsequently lyophilized to exchange protons against deuterons. This procedure was repeated once. Whenever D 2 O was used as the solvent, pH-meter readings are reported rather than pD values (pD values can be derived by adding 0.4 units to the pH-meter reading [18] If not otherwise mentioned, the temperature was maintained at 20³C. Typically, the pulse width was 2.5 Ws (60³ pulse) and the interpulse delay 3 s (the longest T 1 was 0.9 s). The digital resolution was 0.244 Hz/point with a spectral width of 2000 Hz. An exponential multiplication corresponding to 0.5 Hz line broadening was applied to the free induction decay prior to Fourier transformation. The chemical shifts are referenced to external sodium 2,2-dimethyl-2-silapentane-5-sulfonate (DSS). The spin-lattice relaxation times, T 1 , were measured by the inversion-recovery method (180³^d^90³ pulse sequence). In all T 1 experiments the incrementation of the recovery interval was nonmonotonic in order to avoid systematic errors. Peak heights were used for the calculation of T 1 s. Assignments were made in accordance with 1 H-NMR spectra published elsewhere for cipro£oxacin and related £uoroquinolones [19^21] . The H 5 and H 8 protons were distinguished by the relative splitting of the signal. Due to its close proximity to the £uorine in position 6, H 5 was assigned to the signal with the larger coupling constant. The structure of cipro£oxacin is shown in Fig.  1 . The central structural unit is a quinolone ring which has a £uorine atom at the 7-position, a piperazine moiety at the 6-position, a cyclopropyl ring at position 3 and a carboxyl group at position 1. The pK values are 6.0 for the carboxyl group and 8.8 for the 4P nitrogen [22] . Fig. 1 . Structure of cipro£oxacin. The central structural unit is a quinolone ring with a £uorine atom at the 7-position, a piperazine moiety at the 6-position, a cyclopropyl ring at position 1 and a carboxyl group at position 3. There are two pK values, pK aYCOOH = 6.0 and pK aYN4 H = 8.8.
Line-broadening calculations
In the following it is demonstrated how exchange of cipro£oxacin between the membrane and the aqueous phase can lead to signi¢cant broadening of the NMR signals, even though the membrane-associated fraction is very small. The exchange process can be described by equations which were derived for nuclear relaxation in solutions containing paramagnetic ions where exchange occurs between the coordination shell of the paramagnetic ion and the bulk solvent [23, 24] . They were speci¢cally applied to study the di¡usion of water across lipid bilayers, where the internal and external water were distinguished by the presence of paramagnetic ions in either compartment [25, 26] . The spin^spin relaxation is responsible for the line broadening (vX = 1/ZT 2 ). The observed relaxation times, T 2 , depend on the population fractions and exchange rate (1/d ex ) according to:
where T 2Ymem is the relaxation time in the membrane in the absence of exchange, p aq and p mem the population fractions of cipro£oxacin in the aqueous phase and the membrane, and d ex the exchange time of cipro£oxacin between aqueous phase and membrane (or the average residence time of cipro£oxacin in the membrane) [26] . Although insu¤cient information is available concerning the parameters in Eq. 1 to calculate T 2 , a lower limit can be estimated from a theoretical lower bound for T 2Ymem . The lower limit for T 2Ymem is attained if the molecules enter the membrane in a certain state (orientation, conformational state) and exit the membrane without undergoing a change of state. In this case the NMR line shape can be approximated by a Gaussian function and the free induction signal is given by FID(t)Vexp3M [27]. Abragam [28] gives the following formula for the second moment M 2j of a spin j coupled by dipolar interactions to N spins k (k = 1,2,TN) having the same gyromagnetic ratio, Q, as spin j:
jk , where I is the spin of each nucleus and r jk the distance from spin j to spin k [28] . T 2Yeff can be taken as a lower limit for T 2 in the membrane: 
Results
Cipro£oxacin is released rapidly from LUVs in the presence of serum
It has been demonstrated that cipro£oxacin can be accumulated to high concentrations inside liposomes in response to a transmembrane pH gradient [11, 29, 30] . This is illustrated in Fig. 2 . Cipro£oxacin is rapidly accumulated into DPPC/chol LUVs at 60³C, with the uptake going to completion within 5 min. However, it is also rapidly released from the LUVs on incubation in 50% mouse serum at 37³C or depletion of the pH gradient at 25³C in 150 mM ammonium acetate (Fig. 2, right side) . Serum proteins permeabilize the membrane, whereas ammonium acetate dissipates the pH gradient by equilibration of ammonia and acetic acid across the membrane. Cipro£oxacin is also released upon external addition of ammonium sulfate. From this it is evident that cipro£oxacin is able to respond rapidly to changes of thermodynamic equilibria.
Cipro£oxacin does not precipitate in the liposome interior
The concentration of cipro£oxacin inside liposomes can be very high (up to 300 mM). The solubility of cipro£oxacin was determined under the conditions prevailing inside the liposomes. The internal pH after uptake was found to be 4.9 þ 0.1 utilizing radiolabeled methylamine. Before uptake the internal ammonium sulfate concentration is 300 mM; how-ever, the ammonium concentration is reduced by the amount of cipro£oxacin loaded into the LUVs during uptake. Fig. 3 shows the solubility of cipro£ox-acin as a function of ammonium sulfate concentration at 25³C and pH 5, the inset describes the pH dependence in 300 mM ammonium sulfate solutions. The cipro£oxacin precipitate had the form of white needles. The presence of liposomes (5^20 mM DPPC/ chol) had no signi¢cant e¡ect on the solubility of cipro£oxacin in 300 mM ammonium sulfate solution at pH 5 and 3. The solubility at pH 5 and 300 mM ammonium sulfate is 5 mM and increases to about 8.5 mM at pH 3. Solubilities were slightly lower in D 2 O than in H 2 O (20^30%). The intraliposomal concentration of cipro£oxacin at a molar drug-to-lipid ratio of 0.5, 90^95% uptake and an internal volume of 2 Wl/Wmol lipid for 200 nm DPPC/chol LUVs is between 225^240 mM. This exceeds the solubility of free cipro£oxacin by almost 50-fold.
The 1 H-NMR spectrum of cipro£oxacin loaded into 200 nm DPPC/chol LUVs at a drug-to-lipid ratio of 0.5 is depicted in Fig. 4a . For comparison the spectra of the free drug at the same concentration as used for the uptake and that of empty DPPC/chol liposomes are included (Fig. 4b,c) . Two features of the spectrum of encapsulated cipro£oxacin are prominent. First, all resonances are clearly visible though signi¢cantly broadened. The integrated intensities are within 10% of those of the same amount of free cipro£oxacin. Second, large up¢eld shifts of the aromatic proton resonances (H 2 , H 5 , H 8 ) as compared to free cipro£oxacin are observed. The small satellite peaks correspond to non-encapsulated cipro£oxacin in the external medium. The encapsulation e¤ciency was 90% with 10% external cipro£oxacin as determined using the procedures described under Section 2. The solubility data predict that cipro£oxacin should precipitate inside the liposomes. Formation of crystals, however, would lead to disappearance of NMR resonances due to the line broadening associated with the immobilization of the molecules. Precipitation of free cipro£oxacin induced by increasing the pH of the solution results in a proportional loss of signal with no broadening of the lines.
Cipro£oxacin molecules self-associate into small stacks
Experiments were performed to demonstrate that the tendency of cipro£oxacin molecules to self-associate in small stacks in aqueous solution also occurs in the LUV interior. Before describing the experiments, the interactions a¡ecting the NMR spectra are described brie£y. The interactions of aromatic molecules with themselves in solution and their packing in crystals are governed by strong attractive interactions between the aromatic Z-systems [31, 32] . As a consequence of these Z^Z interactions, cipro£ox-acin molecules form stacks in aqueous solutions as well as in crystals where the molecules lie on top of each other in an head-to-tail arrangement [19, 33] . The self-association process in aqueous solution depends on concentration and is highly dynamic with molecules constantly associating and dissociating. Monomers exist only at concentrations below 1 mM. In NMR experiments, the ring currents associated with the circulation of the Z electrons in the plane of the aromatic rings lead to a shielding of protons above and below this plane [34] . The signals of these protons, which in our case are located on neighboring molecules, will appear up¢eld shifted.
The extent of stacking increases with increasing concentration. This is illustrated in Fig. 5 Table 1 . The line widths are not signi¢cantly a¡ected at any concentration. In these experiments the pH was not adjusted. It was shown elsewhere that below pH 5 there is practically no e¡ect of pH on chemical shifts [21] . The highest pH in these experiments was 4.8.
Inside liposomes cipro£oxacin shows the same behavior as far as stacking is concerned. Increasing the drug-to-lipid ratio from 0.05 to 0.7 leads to increasing up¢eld shifts, the ring protons are a¡ected most (Fig. 6, Table 2 ). The small satellite peaks again correspond to non-encapsulated cipro£oxacin. The shifts are much larger for encapsulated cipro£oxacin than for cipro£oxacin free in solution. This can be attributed to the much higher cipro£oxacin concen- trations inside the liposomes (up to 300 mM). In addition, the di¡erent counterions, chloride for the concentration dependence of the drug alone and sulfate inside the liposomes, may a¡ect the shifts slightly di¡erently. A concentration series in ammonium sulfate solutions is not possible because of the low solubility of cipro£oxacin (5 mM in 300 mM ammonium sulfate at pH 5, see Fig. 4 ).
Interaction of cipro£oxacin with the lipid bilayer is responsible for the line broadening
The line widths of entrapped cipro£oxacin decrease with increasing concentration (see Fig. 6 , Table 2). The broadest lines were obtained at the lowest drug-to-lipid ratio (d/l = 0.05) where the internal cipro£oxacin concentration is in the range of 25 mM. This is in contrast to the behavior of cipro£oxacin in solution where the line width did not change signi¢-cantly with increasing concentration up to 115 mM which is just slightly less than its solubility in D 2 O.
The broadening also appears larger in POPC liposomes than in DPPC/chol LUVs ( Table 2 ). External addition of cipro£oxacin to 200 nm POPC liposomes with no transmembrane pH gradient leads to signi¢-cant line broadening ( Fig. 7 and Table 2 , d/l = 0.5 with 150 mM NaCl in-and outside). The line width of the H 2 proton increases with decreasing concentration much more than the others (not shown). The width of the water peak does not change in the presence of liposomes. Fig. 7a ,c are the spectra of cipro£oxacin alone in 150 mM NaCl and cipro£oxacin loaded into POPC liposomes at the same d/l ratio. Therefore, the main contribution to the line broadening must arise from an interaction of cipro£oxacin with the liposomes.
Only a small proportion of cipro£oxacin partitions into the lipid bilayer
Binding studies performed by ultracentrifugation demonstrated that the amount of cipro£oxacin associated with DPPC/chol liposomes is less than 3% of the total amount of drug initially added (for the conditions see Section 2). This percentage was determined by assaying the lipid pellet and does not account for the drug in the aqueous volume included in the pellet. A determination in the supernatant was not possible since its accuracy corresponds to the level of association. Therefore, this 3% value represents an upper limit for the amount of drug associated with the lipid. This corresponds to a maximum partition coe¤cient, K p , of 0.03, where K p = c mem /c aq with c aq and c mem being the concentrations of drug in the membrane and aqueous phase, respectively. These data clearly indicate that almost all (v 97%) of the drug is located in the aqueous interior of the liposomes. This is also corroborated by integration Table 2 . of the NMR spectra of free and entrapped drug (see above). A further quantitation was not attempted. In addition, if signi¢cant amounts of drug were associated with the lipid e¡ects on the lipid headgroup, proton resonances would be expected. The trimethyl ammonium group should be particularly a¡ected by the ring currents associated with the aromatic rings of cipro£oxacin if signi¢cant amounts of cipro£oxacin reside in close proximity ( 6 8 A î ) . Shifts between 10 Hz and more than 100 Hz have been found for benzylalcohol, indole-3-acetic acid, aromatic lipophilic drugs such as dibucaine as well as the surface potential probe ANS (1-anilino-8-naphthalenesulfonate) [35^38] . However, uptake of cipro£oxacin into 80 nm diameter POPC liposomes does not result in an up¢eld shift of the trimethyl lipid headgroup protons, even at a d/l ratio of 0.5. Addition of Pr 3 to the external medium separates the signal of the trimethyl protons of the inner monolayer from that of the outer by shifting the latter down¢eld [39] . The signal from the inner monolayer remained essentially unchanged (shifted up¢eld by 1^2 Hz) in the presence of entrapped drug.
The above data indicate that self-association and lipophilicity can be excluded as the source of line broadening for encapsulated cipro£oxacin. The most likely explanation involves rapid exchange of drug into and out of the membrane, where only a small fraction of drug actually resides in the membrane.
Discussion
Many drugs, which are weak bases, can be accumulated to high concentrations in liposomes in response to a transmembrane proton gradient. However, uptake and retention properties are strongly drug dependent. For example, accumulation of drugs such as doxorubicin leads to high levels of drug uptake and excellent retention [8, 9, 12, 40, 41] . Alternatively, drugs such as cipro£oxacin exhibit poor retention properties. The interrelationship between the retention properties of cipro£oxacin loaded into LUVs and its nature and location inside liposomes is the subject of this study. The following discussion will focus on the anomalous solubility of cipro£ox-acin and the lack of precipitation in the liposome interior, and second, the exchange of cipro£oxacin into and out of the lipid membrane with regard to NMR line-broadening e¡ects.
The cipro£oxacin concentrations inside liposomes can exceed 250 mM. However, the drug does not precipitate inside the liposomes even though the solubility of cipro£oxacin in bulk aqueous solution under the same pH and ionic strength conditions as in the liposome interior is only 5 mM. Self-associa- tion of cipro£oxacin molecules into small stacks is observed. The extent of stacking as indicated by the up¢eld shifts of the NMR lines is larger in the liposome interior due to the higher internal drug concentrations. The reason for the anomalously high solubility of cipro£oxacin in the LUV interior remains obscure. One possibility concerns the nature of the water in the LUV interior. It is known that the properties of water at interfaces and con¢ned to small spaces are very di¡erent from that of bulk water. Water is highly structured at interfaces, with lower density and higher viscosity than bulk water [42, 43] . The distances over which the water structure is a¡ected is a matter of dispute, estimates range from 10^30 A î up to 1000 A î [44, 45] . Anomalous properties of water were also reported in Sephadex gels where the internal water could dissolve signi¢-cant amounts of water-insoluble dyes [46, 47] . An alternative possibility is that the phospholipid surface may act as an inhibitor of crystallization in the same way as macromolecules exert speci¢c control of mineralization processes [48^50] . Biomimetic studies of mineral formation in synthetic phospholipid vesicles have shown that the lipid composition has a dramatic e¡ect on the precipitation kinetics and the size and location of the intravesicular precipitate [51] . For example, the rate and extent of precipitation of calcium phosphate in the interior of liposomes was extremely low in the presence of 10 mol% phosphatidic acid (PA), but not in the presence of other anionic phospholipids [52, 53] .
The results presented here indicate that almost all (v 97%) of the encapsulated drug is located in the aqueous interior of the liposomes. Nevertheless, all 1 H-NMR resonances are considerably broadened with line widths up to 45 Hz as compared to 4^15 Hz for free cipro£oxacin (see Table 2 ). The decrease in line widths at high intraliposomal cipro£oxacin concentrations and the negligible e¡ect of stacking on line widths rules out self-association and precipitation of cipro£oxacin as sources of broadening. However, exchange of cipro£oxacin between the membrane and the aqueous phase is a reasonable mechanism for the observed line broadening (see Section 2.10). According to this model, the NMR resonances are broader the higher the fraction of cipro£oxacin in the membrane and/or the`faster' the exchange (see Section 2, Eq. 1). For water exchange between the bulk solution and the aqueous interior of DPPC SUVs it has been shown that d ex dominates the relaxation times at low temperatures [26] . The partition coe¤cient of small molecules for POPC membranes is higher than for DPPC/chol membranes [54^56]. This could explain why cipro£oxacin resonances are broader in POPC than in DPPC/chol liposomes. The fact that the line widths decrease with increasing internal cipro£oxacin concentrations can be explained by considering the change in relative population fractions. Reduced p mem or higher p aq lead to a decrease in line width. Increasing the total concentration of cipro£oxacin causes an increase in the fraction of drug in the aqueous phase when the membrane is saturated. Concomitantly, a second competing exchange process, the increased self-association of cipro£oxacin with increasing concentration, may contribute to reduce the amount of the exchangeable species, the monomer.
The high solubility of cipro£oxacin in the intraliposomal space and its ability to rapidly exchange into and out of a lipid membrane correlate well with the high tissue penetration of this drug and its accumulation within mammalian cells, factors which are responsible for the broad spectrum of activity of the £uoroquinolone antibiotics against extracellular as well as intracellular pathogens [57^59].
Finally, strategies to improve the retention of cipro£oxacin are discussed. While depletion of the pH gradient results in rapid leakage of cipro£oxacin from liposomes other drugs such as doxorubicin are retained much longer. Thus the e¡ect of the pH gradient can be modulated by other parameters. Precipitation of drugs in the liposome interior as well as drug partitioning into the lipid bilayer have been identi¢ed as leakage retarding factors [9, 12, 41] . In a subsequent study we have shown that the retention of cipro£oxacin can be improved upon inclusion of negatively charged lipids into the LUV formulations consistent with the partitioning model [29, 41] .
In summary, cipro£oxacin does not precipitate inside liposomes following accumulation in response to a transmembrane pH gradient even though the internal drug concentration can be much higher than its solubility in the bulk aqueous phase. In addition, only a very small proportion of the entrapped drug can partition into the inner monolayer of the LUV. We suggest that the soluble nature of internalized cipro£oxacin is directly related to the rapid leakage of the drug following changes in electrochemical equilibria.
